Soon, you'll be able to cruise to your destination without a driver in Houston. Photo via Cruise/Facebook

Anew driverless ridehail service is coming to Houston: Cruise, the all-electric, driverless car company backed by GM, is expanding in Texas with launches in both Dallas and the Bayou City.

This follows an initial launch in Austin in 2022, their first city in Texas.

Cruise builds and operates driverless vehicles that you can call via an app, like any other ride hailing service. "But our vehicles show up without anyone else inside," they say.

The entire fleet is all-electric and the vehicles are equipped with a 360-view, with the ability to react to whatever they encounter on the road.

They test their vehicles using simulations, through millions of scenarios and virtual miles; they’ve also driven more than 4 million real miles, mostly in San Francisco.

They have not defined what the cost will be but according to The Verge, the rates in San Francisco vary depending on length of trip and time of day: "A customer taking a 1.3-mile trip would pay 90 cents per mile and 40 cents per minute, in addition to a $5 base fee and 1.5 percent city tax, for a total of $8.72." By comparison, an Uber ride for the same trip would cost at least $10.41.

The company was founded in 2013 and vehicles began to hit the road in 2022. They operate a total fleet of roughly 300 all-electric AVs, powered 100 percent by renewable energy. In addition to Austin, they operate in San Francisco and Phoenix, where they've completed 35,000 self-driving deliveries in a partnership with Walmart.

According to a statement from CEO Kyle Vogt, they'll begin supervised driving (with a safety driver behind the wheel) in Houston as they finetune their AI technology to understand the nuances and unique elements of the city, with Dallas to follow shortly after.

In a blog post, Vogt says their cars drive the speed limit and come to a complete stop at every stop sign. They respond to police sirens, flashing lights on fire trucks or ambulances, and stop signs that fold out of school buses.

They react to people on scooters, people using bike lanes, and cars driving on the wrong side of the road. "In short, they are designed to drive safely by obeying the law and driving in a humanlike way," he says. Actually, that sounds better than humans.

When vehicles encounter a situation where they aren’t 100 percent sure of what to do, they slow down or stop and pull over to the side of the road. This has caused some bumps in San Francisco where cars stopped and idled in the street for no apparent reason, delaying bus riders and disrupting the work of firefighters.

Photo via Cruise/Facebook

Some of the "bumps" have been comical, such as the 2022 incident in which a confused San Francisco police officer pulled a Cruise over, and then the Cruise drove away.

And as Reuters notes, autonomous vehicles have not rolled out as fast as anticipated, due to regulations, safety investigations, and arduous technology.

When Cruise first enters a city, they hire a mapping and data collection team to learn bike lanes, school zones, and major intersections. But most of the time, the vehicles will be carrying riders in the back seat, or completely empty and en route to another pickup.

The company partners with first responders, including police and fire departments, to ensure they’re ready and familiar with how to interact with the vehicles, engaging with those agencies before and after launch.

"Our guiding mission has always been to improve road safety, reduce emissions, and reduce congestion with our driverless ride-hail service in cities, which is where we’ll see the most significant positive impact the soonest," Vogt says. "Houston and Dallas are committed to reducing traffic deaths as part of their Vision Zero commitments, and we are excited to operate in and partner with these new communities in this shared mission."

------

This article originally ran on CultureMap.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Texas tops ranking of best state for investors in new report

by the numbers

Texas ranks third on a new list of the best states for investors and startups.

Investment platform BrokerChooser weighed five factors to come up with its ranking:

  • 2024 Google search volume for terms related to investing
  • Number of investors
  • Number of businesses receiving investments in 2024
  • Total amount of capital invested in businesses in 2024
  • Percentage change in amount of investment from 2019 to 2024

Based on those figures, provided mostly by Crunchbase, Texas sits at No. 3 on the list, behind No. 1 California and No. 2 New York.

Especially noteworthy for Texas is its investment total for 2024: more than $164.5 billion. From 2019 to 2024, the state saw a 440 percent jump in business investments, according to BrokerChooser. The same percentages are 204 percent for California and 396 percent for New York.

“There is definitely development and diversification in the American investment landscape, with impressive growth in areas that used to fly under the radar,” says Adam Nasli, head analyst at BrokerChooser.

According to Crunchbase, funding for Texas startups is off to a strong start in 2025. In the first three months of this year, venture capital investors poured nearly $2.9 billion into Lone Star State companies, Crunchbase data shows. Crunchbase attributes that healthy dollar amount to “enthusiasm around cybersecurity, defense tech, robotics, and de-extincting mammoths.”

During the first quarter of this year, roughly two-thirds of VC funding in Texas went to just five companies, says Crunchbase. Those companies are Austin-based Apptronik, Austin-based Colossal Biosciences, Dallas-based Island, Austin-based NinjaOne, and Austin-based Saronic.

Autonomous truck company rolls out driverless Houston-Dallas route

up and running

Houston is helping drive the evolution of self-driving freight trucks.

In October, Aurora opened a more than 90,000-square-foot terminal at a Fallbrook Drive logistics hub in northwest Houston to support the launch of its first “lane” for driverless trucks—a Houston-to-Dallas route on the Interstate 45 corridor. Aurora opened its Dallas-area terminal in April and the company began regular driverless customer deliveries between the two Texas cities on April 27.

Close to half of all truck freight in Texas moves along I-45 between Houston and Dallas.

“Now, we are the first company to successfully and safely operate a commercial driverless trucking service on public roads. Riding in the back seat for our inaugural trip was an honor of a lifetime – the Aurora Driver performed perfectly and it’s a moment I’ll never forget,” Chris Urmson, CEO and co-founder of Pittsburgh-based Aurora, said in a news release.

Aurora produces software that controls autonomous vehicles and is known for its flagship product, the Aurora Driver. The software is installed in Volvo and Paccar trucks, the latter of which includes brands like Kenworth and Peterbilt.

Aurora previously hauled more than 75 loads per week under the supervision of vehicle operators from Houston to Dallas and Fort Worth to El Paso for customers in its pilot project, including FedEx, Uber Freight and Werner. To date, it has completed over 1,200 miles without a driver.

The company launched its new Houston to Dallas route with customers Uber Freight and Hirschbach Motor Lines, which ran supervised commercial pilots with Aurora.

“Transforming an old school industry like trucking is never easy, but we can’t ignore the safety and efficiency benefits this technology can deliver. Autonomous trucks aren’t just going to help grow our business – they’re also going to give our drivers better lives by handling the lengthier and less desirable routes,” Richard Stocking, CEO of Hirschbach Motor Lines, added in the statement.

The company plans to expand its service to El Paso and Phoenix by the end of 2025.

“These new, autonomous semis on the I-45 corridor will efficiently move products, create jobs, and help make our roadways safer,” Gov. Greg Abbott added in the release. “Texas offers businesses the freedom to succeed, and the Aurora Driver will further spur economic growth and job creation in Texas. Together through innovation, we will build a stronger, more prosperous Texas for generations.”

In July, Aurora said it raised $820 million in capital to fuel its growth—growth that’s being accompanied by scrutiny.

In light of recent controversies surrounding self-driving vehicles, the International Brotherhood of Teamsters, whose union members include over-the-road truckers, recently sent a letter to Lt. Gov. Dan Patrick calling for a ban on autonomous vehicles in Texas.

“The Teamsters believe that a human operator is needed in every vehicle—and that goes beyond partisan politics,” the letter states. “State legislators have a solemn duty in this matter to keep dangerous autonomous vehicles off our streets and keep Texans safe. Autonomous vehicles are not ready for prime time, and we urge you to act before someone in our community gets killed.”

Houston cell therapy company launches second-phase clinical trial

fighting cancer

A Houston cell therapy company has dosed its first patient in a Phase 2 clinical trial. March Biosciences is testing the efficacy of MB-105, a CD5-targeted CAR-T cell therapy for patients with relapsed or refractory CD5-positive T-cell lymphoma.

Last year, InnovationMap reported that March Biosciences had closed its series A with a $28.4 million raise. Now, the company, co-founded by Sarah Hein, Max Mamonkin and Malcolm Brenner, is ready to enroll a total of 46 patients in its study of people with difficult-to-treat cancer.

The trial will be conducted at cancer centers around the United States, but the first dose took place locally, at The University of Texas MD Anderson Cancer Center. Dr. Swaminathan P. Iyer, a professor in the department of lymphoma/myeloma at MD Anderson, is leading the trial.

“This represents a significant milestone in advancing MB-105 as a potential treatment option for patients with T-cell lymphoma who currently face extremely limited therapeutic choices,” Hein, who serves as CEO, says. “CAR-T therapies have revolutionized the treatment of B-cell lymphomas and leukemias but have not successfully addressed the rarer T-cell lymphomas and leukemias. We are optimistic that this larger trial will further validate MB-105's potential to address the critical unmet needs of these patients and look forward to reporting our first clinical readouts.”

The Phase 1 trial showed promise for MB-105 in terms of both safety and efficacy. That means that potentially concerning side effects, including neurological events and cytokine release above grade 3, were not observed. Those results were published last year, noting lasting remissions.

In January 2025, MB-105 won an orphan drug designation from the FDA. That results in seven years of market exclusivity if the drug is approved, as well as development incentives along the way.

The trial is enrolling its single-arm, two-stage study on ClinicalTrials.gov. For patients with stubborn blood cancers, the drug is providing new hope.